Approaches to improving mental health care for autistic people: a systematic review
===================================================================================

* Sofia Loizou
* Tamara Pemovska
* Theodora Stefanidou
* Una Foye
* Ruth Cooper
* Ariana Kular
* Anna Greenburgh
* Helen Baldwin
* Jessica Griffiths
* Katherine R. K. Saunders
* Phoebe Barnett
* Matilda Minchin
* Gráinne Brady
* Nafiso Ahmed
* Jennie Parker
* Beverley Chipp
* Rachel Rowan Olive
* Robin Jackson
* Amanda Timmerman
* Suzi Sapiets
* Eva Driskell
* Bethany Parsons
* Debbie Spain
* Vaso Totsika
* Will Mandy
* Richard Pender
* Philippa Clery
* Kylee Trevillion
* Brynmor Lloyd-Evans
* Alan Simpson
* Sonia Johnson

## Abstract

**Background** Autistic people have a high likelihood of developing mental health difficulties but a low chance of receiving effective mental health care. Therefore, there is a need to identify and examine strategies to improve mental health care for autistic people.

**Aims** To identify strategies that have been implemented to improve access, experiences of care and mental health outcomes for autistic adults and examine evidence on their acceptability, feasibility and effectiveness.

**Method** A co-produced systematic review was conducted. MEDLINE, PsycINFO, CINHAL, medRxiv and PsyArXiv were searched. We included all study designs reporting acceptability or feasibility outcomes and empirical quantitative study designs reporting effectiveness outcomes. Data were synthesised using a narrative approach.

**Results** A total of 29 articles were identified. These included 16 studies of adapted mental health interventions, seven studies of service improvements and six studies of bespoke mental health interventions developed for autistic people. There was no conclusive evidence on effectiveness. However, most bespoke and adapted approaches appeared to be feasible and acceptable. Identified adaptations appeared to be acceptable and feasible, including increasing knowledge and detection of autism, providing environmental adjustments and communication accommodations, accommodating individual differences, and modifying the structure and content of interventions.

**Conclusion** Many identified strategies are feasible and acceptable and can be readily implemented in services with the potential to make mental health care more suitable for autistic people, but important research gaps remain. Future research should address these and investigate a co-produced package of service improvement measures.

Keywords
*   autism spectrum condition
*   mental health
*   adaptations
*   adults
*   mental health care

## Introduction

Autistic1 people (1) experience a high rate of mental health difficulties but are less likely to receive effective mental health support (2). For autistic people, co-occurring mental health difficulties can lead to negative outcomes including poor quality of life (3–5) and increased risk of suicide (6–8). Accessing appropriate support from mental health services can be a critical step towards addressing mental health difficulties in autistic people. Dissatisfaction with care (9), high levels of unmet needs (10), and harmful effects (11) suggest that mental health services do not currently provide sufficient support for many autistic individuals with co-occurring mental health difficulties. This can erode trust in services and prevent help-seeking in the future (11).

Clinicians may struggle to distinguish autistic traits from symptoms of mental health conditions due to similarities in external presentation (8,12–14), which together with lack of clinician knowledge of autism (15) creates difficulties for autistic people accessing and receiving appropriate mental health support. This may lead to delayed or missed autism diagnosis, misdiagnosis, and ultimately ineffective treatment and support (16). Hence, there is a need to identify strategies to facilitate the detection of autism within mental health services.

Another potential barrier to obtaining high quality and appropriate mental health support is the lack of tailored care, as autistic people and their families recurrently report that services and treatment approaches are rarely adapted to their needs (15). Impediments to delivering appropriate support include lack of staff training and knowledge on how services could be adapted, and lack of evidence on best approaches (11,17–20). This scarcity of tailored approaches and lack of information about effective tailored care further highlights the need to identify strategies used to improve access, experiences of care and mental health outcomes for autistic people.

The aim of this review was to lay foundations for care that better meets the needs of autistic people by identifying and examining strategies that intend to improve mental health treatment and care for autistic adults. This was addressed through the following research questions: 

1.  What strategies, including bespoke and adapted mental health interventions, service adaptations and strategies to detect autism, have been developed to improve mental health care for autistic people?

2.  What is the acceptability and feasibility of strategies to improve mental health care for autistic people?

3.  What is the effectiveness of strategies to improve mental health care for autistic people?

## Methods

Our systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines (21). A PRISMA checklist for this review is available in Table S1. The review was commissioned from the National Institute for Health and Care Research (NIHR) Mental Health Policy Research Unit (a research unit funded to deliver evidence to inform mental health policy in England) to meet an identified need for more evidence to guide policy in this area. We developed a review protocol that was prospectively registered on PROSPERO (CRD42022347690). The review protocol was developed through consultations with the review’s working group, which included lived experience researchers (i.e., people drawing on relevant lived experience to inform research), academics, clinicians and policy experts. All members of the working group had personal or professional expertise in autism and/or systematic review methodology. The working group met once a month from the inception of the review in July 2022 until its completion in March 2023. In the current paper, we have presented the findings regarding autistic adults and regarding mixed samples of adults and children and young people (CYP) populations in which only combined outcomes were reported. The findings for CYP will be reported in a separate paper.

### Search Strategy

Three electronic databases (MEDLINE (01/01/1994-DATE), PsycINFO (01/01/1994-DATE) and CINHAL (01/01/1994-DATE) and two pre-print servers (medRxiv and PsyArXiv) were searched using a combination of keyword and subject heading searches of terms for autism spectrum disorders and services/treatments and mental health problems. The search was restricted to studies published since 1994, to cover the Diagnostic and Statistical Manual of Mental Disorders fifth (DSM-IV) and fourth (DSM-V) edition periods. The reference lists of identified relevant systematic reviews were searched, and experts including academics and lived experience networks were contacted to identify relevant papers. The full search strategy can be found in Tables S2-S4.

### Inclusion and exclusion criteria

#### Population

For studies evaluating the effectiveness and/or acceptability/feasibility of treatment, we included adults (18+ years) and mixed samples of adults and CYP with an autism diagnosis, or who suspected they were autistic, or who were identified by clinicians as potentially autistic. Perspectives of carers and clinicians providing treatment to this population were also included. In all studies apart from those that explored detection of autism in mental health services, we excluded those with samples that included both autistic people and non-autistic people, unless data were reported separately for the autistic group.

#### Strategies

We included any bespoke or adapted mental health intervention (pharmacological, non-pharmacological or combinations) specifically for autistic people receiving mental health care from specialist mental health services and/or in primary care. We included studies describing and characterising bespoke or adapted mental health interventions for autistic people, or reporting on adaptations intended to improve access, experiences of care and mental health outcomes or strategies to identify autism in mental health services. Studies with any kind of comparison group (e.g., standard care, bespoke interventions or adapted approaches), or without a comparison group, were included.

#### Outcomes

We included any quantitative measure or qualitative account of feasibility (e.g., recruitment adherence and retention rates), service use (e.g., engagement), acceptability of care and experiences and satisfaction with care at end of treatment or follow-up for the second review question (RQ2). We also included any quantitative measure of mental health, detection of autism, quality of life, service use (e.g., inpatient admission, acute crisis care), and social outcomes (e.g., social functioning) at end of treatment or follow-up for the third review question (RQ3). Studies measuring physical health outcomes only were excluded.

#### Study types

All study designs and service descriptions reporting acceptability and feasibility outcomes were eligible for RQ2. Only empirical quantitative study designs, including service evaluations and clinical audits were eligible for RQ3. We excluded systematic or narrative reviews, small-N case studies, commentaries, book chapters, editorials, letters, conference abstracts and theses.

### Study selection

Two members of the review team (TS, PB) piloted the selection strategy. Title and abstract screening was conducted by members of the review team (AK, TS, KS, AG, TP, UF) with 10% of the search records reviewed in duplicates. The full text of eligible articles were then screened by members of the review team (TP, AG, AK, TS, DS, KS, SL, RC, JG, HB, UF), with 10% reviewed in duplicate. Conflicts were resolved by discussion and consultation with a third reviewer (SJ or VT) and with the working group. In instances where the setting or the intervention was unclear, study authors were contacted to determine eligibility. Study selection was carried out in Rayyan (22).

### Data extraction

Following study selection, members of the review team including lived experience researchers (TP, AG, AK, TS, DS, UF, SL, JG, HB, AT, MM, GB, RC) extracted the following: study design, aims, setting, sample size, participant characteristics (e.g., age, ethnicity, sex, diagnosis), outcome measures, strategies or adaptations (e.g., type and brief description) and relevant findings (feasibility, acceptability and effectiveness). The data extraction form was first piloted on 10% of the included studies (SL, RC) and revised accordingly based on feedback from the working group.

In response to the observation by lived experience researchers working on the study that a bias towards neurotypical people’s perspectives on autistic people’s difficulties was apparent in multiple studies, a decision was made in the working group to pilot a method of assessing this. Criteria for exploring the potential neurotypical bias in the included studies were developed by a lived experience researcher (RRO) based on a combination of existing literature and personal experience and piloted by members of the team (SL, TP). The five criteria used to assess the potential neurotypical bias were: 1) reported involvement from people with lived experience in the design, conduct, or write-up of the study; 2) for studies with qualitative elements, reported adjustments made to the data collection process (23); 3) for studies with quantitative elements, reported adjustments made to the data collection tools (24); 4) for studies with quantitative elements, reported adaptations or validity of relevant outcome measures for autistic people; 5) for studies with quantitative elements, perceived focus of the tested intervention/strategy on masking/changing autistic traits which might have not inherently impacted quality of life or caused distress (e.g., use of outcome measures relating to social skills or explicitly seeking to reduce autism symptoms) (25). Data for all criteria were extracted from the included studies by two researchers (AG, AK), with lived experience researchers (RJ, JP) as second assessors of the final criterion.

### Quality assessment and certainty of evidence

The Mixed Methods Appraisal Tool (MMAT) (26) was used to assess study quality. This is an established tool for evaluating quantitative, qualitative and mixed methods studies. Scores range from zero (low quality) to five (high quality). The Grading of Recommendations Assessment, Development and Evaluation (GRADE) system (27), adapted for narrative synthesis (28) was used to assess the strength of the evidence contributing to effectiveness outcomes. Two reviewers independently (TP, SL) assessed each outcome and addressed inconsistencies before reaching consensus.

### Data synthesis

A narrative synthesis was undertaken following Economic and Social Research Council (ESRC) guidelines (29). All identified intervention-level and service-level adaptations were grouped based on shared commonalities (e.g., environmental adjustments, adapted communication) to develop top-level and sub-level categories. Category development was informed by the input of lived experience researchers. Two meetings were held with lived experience researchers, in addition to the monthly working groups meetings, to share their views on the generated categories. Lived experience researchers were also given the opportunity to provide written feedback. To present extracted data, articles were categorised by the type of strategy (i.e., adaptations to mental health interventions, service improvements/adaptations or bespoke strategies) and study design (i.e., randomised controlled trials [RCTs], non-randomised controlled trials, surveys, before-and-after comparisons, and service evaluations). Extracted data related to the five criteria used to assess the potential neurotypical bias were synthesised descriptively. The review findings presented below have been refined and interpreted through discussions with and feedback from the working group.

## Results

The PRISMA flow diagram is shown in Figure 1. In total, 29 articles met the inclusion criteria. A list of included studies can be found in Table S5.

![Figure 1.](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2023/03/10/2023.03.10.23287101/F1.medium.gif)

[Figure 1.](http://medrxiv.org/content/early/2023/03/10/2023.03.10.23287101/F1)

Figure 1. 
PRISMA flowchart

### Study design

Of the 29 articles, two were RCTs (30,31), three were pilot RCTs (32–34), three were non-randomised controlled trials (35–37), two were qualitative (38,39), one was retrospective analytical cross-sectional (40), four were surveys (41–44), four were service evaluations (45–48), and 10 were before-after comparison studies (49–58). Two of these articles were from the same trial (33,38). Study characteristics are described in detail in Tables 1 and S6.

View this table:
[Table 1.](http://medrxiv.org/content/early/2023/03/10/2023.03.10.23287101/T1)

Table 1. 
Study characteristics (*N* = 29)

### Quality assessment

According to appraisal using the MMAT (26), 18 studies (four randomised controlled, six non-randomised, three quantitative descriptive, three mixed, two qualitative) were of high quality (≥4 criteria met), six studies (all non-randomised) were of moderate quality (3 criteria met) and five studies (four non-randomised, one mixed) were of low quality (≤2 criteria met). All MMAT ratings can be seen in Table S7.

### Assessment of neurotypical bias

Seven out of 29 studies (24%) reported that autistic people were involved in conducting the study. None of the eight studies with a qualitative element reported any adjustments to the data collection process (e.g., allowing non-verbal/non-oral communication). Two out of 27 studies (7%) with a quantitative element reported making some adjustments to the data collection tools (e.g., adapting Likert scales for greater precision, using straightforward language). Ten out of 27 studies (37%) with a quantitative element reported on the psychometric properties or adaptations of the relevant outcome measures to make them more appropriate for autistic individuals. Six out of the 10 studies (60%) used at least one adapted or validated outcome measure relevant to the review, and the remaining four studies (40%) stated that the relevant outcome measures had not been validated or adapted specifically for autistic people. For five of the 21 studies (24%) with a quantitative element that measured outcomes in autistic mental health service users, the intervention/strategy were perceived to involve some focus on masking people’s autistic traits. However, thirteen of the 21 studies (62%) were not perceived to have any evidence to suggest such a focus, and this was unclear for three of the twenty-one studies (14%). See Table S8 for all extracted data related to the neurotypical bias assessment.

### Sample characteristics

Sample sizes at baseline were small across most studies, ranging from 7 to 1487 (median 103, n = 28 studies). Twenty-four studies included participants who were service users. All participants of these studies had a diagnosis of autism except for two studies relating to the detection of autism, which included people who had not been diagnosed as autistic at the time study data were obtained (40,41). Only one study included participants with intellectual disability (ID) (47).

Twenty studies reported on co-occurring mental health conditions at baseline: obsessive compulsive disorder (OCD) (30,51), depression (33,38), anxiety (32,54), post-traumatic stress disorder (PTSD) (36), stress (34), eating disorders (48) and a combination of mental health difficulties (31,35,37,40,41,45,50,53,55,56,58). Sixteen papers reported on adults (31,33,34,36–38,40,45,48,51–57) seven papers reported on both CYP and adults (30,32,35,47,49,50,58). Five papers reported on staff perspectives of how to adapt and deliver better care for autistic people across the lifespan (39,42–44,46). Sample characteristics are described in detail in Table S6.

### Types of strategies used to improve mental health care in autism

#### Intervention-level and service-level adaptations

Studies tended to use several adaptations; hence most studies were found to be relevant to multiple categories. The following six top-level adaptation categories were identified: communication accommodations (n = 16), intervention content (n = 13), intervention structure (n = 9), increase knowledge and detection of autism (n = 8), accommodate individual differences (n = 8) and environmental adjustments (n = 4). Tables 2 and S9 describe the adaptations in each study. Most studies reported a general rationale for adaptations (e.g., to address barriers and needs of autistic people). Individual adaptations often lacked a comprehensive description and rationale.

View this table:
[Table 2.](http://medrxiv.org/content/early/2023/03/10/2023.03.10.23287101/T2)

Table 2. 
All service-level and intervention-level adaptations (simplified version) (*N* = 23)

Sixteen articles described studies of mental health interventions that had been adapted to make them more appropriate for autistic people. These included adaptations of Cognitive Behavioural Therapy (CBT) for anxiety (49,50,58), CBT for OCD (30,51), mindfulness-based therapy for autism spectrum disorders (MBT-AS) (31,53), Eye Movement Desensitisation and Reprocessing (EMDR) (36,43), guided self-help CBT for depression (33,38), acceptance and commitment therapy (ACT) (56), Schema therapy (55), mindfulness-based stress reduction (MBSR) (37), CBT for anxiety and depression (37), CBT aimed to reduce general psychological distress (42,45). No trials directly compared adapted and non-adapted mental health interventions; hence no conclusions could be drawn as to whether specific adaptations resulted in better outcomes.

Seven articles described studies investigating service adaptations, largely related to autism-specific training of staff and environmental adjustments. These studies examined clinical pathways (48), models (46), networks (47) and general adaptations (39,44) to improve quality of mental health care for autistic people, and initiatives to improve the detection of autism (40,41).

#### Bespoke mental health interventions

Six studies examined bespoke mental health interventions designed for autistic people. These were individual Real-Time Stress Management (RTSM) using a mobile platform (52), CBT for anxiety (32), CBT for social anxiety (57), CBT for anxiety in combination with Virtual Reality (54), CBT for anxiety, stress and depression (35) and animal assisted therapy (AAT) (34).

### Evaluation of strategies used to improve mental health care in autism

#### Certainty of evidence for effectiveness of strategies

Results from twenty-three studies contributed to the GRADE assessment. The certainty of evidence for the effectiveness of strategies (n = 19), as rated using the GRADE system (27), ranged from very low to moderate (Table S10). No strategies were assessed to have high-certainty evidence for effectiveness and only three out of 19 (16%) strategies were deemed to have moderate-certainty effectiveness evidence, i.e., adapted individual CBT interventions for anxiety (50,58) and for OCD (30,51), and strategies for detection of autism (40,41). Certainty of evidence for effectiveness was generally very low or low for the remaining included strategies (53% and 32%, respectively).

#### Adaptations to mental health interventions

Overall, most adapted mental health interventions were evaluated as feasible and acceptable, except for one study of CBT for OCD, which showed limited feasibility (51). Individual adaptations were largely viewed positively (38,50), and clinicians reported frequently used adaptations to CBT (42) and EMDR (43). Evidence on effectiveness was inconclusive as RCTs were not sufficiently powered and most were before-and-after comparison studies. The main findings of adapted mental health interventions can be found in Tables 3 and 4, and detailed results of individual studies are available in Table S11.

View this table:
[Table 3.](http://medrxiv.org/content/early/2023/03/10/2023.03.10.23287101/T3)

Table 3. 
Main findings of adaptations to individual mental health interventions

View this table:
[Table 4.](http://medrxiv.org/content/early/2023/03/10/2023.03.10.23287101/T4)

Table 4. 
Main findings of adaptations to group mental health interventions

#### Randomised controlled trials (RCTs) and pilot RCTs

Three trials, including one pilot, evaluated adapted mental health interventions. One RCT found that compared to waiting list, adapted group MBT-AS led to significant improvements in all mental health outcomes including depression, anxiety, positive affect and rumination (31). The intervention also had a low drop-out rate and a high attendance rate. Another RCT found no significant differences in treatment satisfaction and in primary (clinician-assessed OCD symptoms) and secondary (self-report OCD symptoms, anxiety and depression) mental health post-treatment outcomes between adapted individual CBT for OCD and adapted individual anxiety management, apart from parent-report OCD symptoms that significantly reduced only in the anxiety management group over time (30). Attendance rates were higher in the CBT arm; however, drop-out rates were similar in both groups. Neither RCT was sufficiently powered to demonstrate an effect. A pilot RCT comparing adapted individual guided self-help CBT for depression and TAU found that the former had a lower drop-out rate, whilst also achieving an acceptable attendance rate (33). A subsequent qualitative study (38) using a subset of the sample demonstrated that the intervention was also viewed positively by most participants. However, there were differing views about the pacing of the sessions and the use of pre-defined visual tools.

#### Non-randomised controlled trials

Two non-randomised controlled trials evaluated adapted mental health interventions. A study comparing the effectiveness of adapted group MBSR and adapted group CBT for anxiety and depression reported no significant differences in mental health outcomes of anxiety, depression, positive and negative general mood and rumination at post-treatment (37). Both MBSR and CBT were adapted in the same way (see Tables 4 and S9). A study with a non-randomised add-on design reported significant improvements in PTSD symptoms and psychological distress following EMDR + TAU compared to TAU only (36). The effect remained stable at 6-8 weeks follow-up. The study showed a low drop-out rate and, whilst all participants found EMDR sessions stressful, most indicated that they would choose the therapy again.

#### Surveys investigating perspectives of staff

Two surveys examined the perspectives of staff of adapted interventions to improve mental health care for autistic people. One survey found that most adaptations to CBT targeting psychological distress (e.g., use of plain English, structured and concrete approach) were highly endorsed by therapists, while others appeared to be used less consistently (e.g., shorter or longer sessions, avoidance of metaphors) (42). Findings from a Delphi survey reported an array of adaptations identified by therapists as always, often or sometimes incorporated in EMDR (43). These included environmental adjustments, normalising experiences, communicating clearly, being flexible with the treatment manual, taking a slow approach and considering the role of autism within conceptualisation.

#### Before-and-after comparison studies

Eight before-and-after comparison studies examined adapted mental health interventions. Significant improvements in outcomes over time were reported in all studies (Tables 3 and 4). However, causality cannot be inferred as there were no comparison groups, thus these will not be reported in detail.

A pre-post study of group CBT for social anxiety reported a low drop-out rate and a high participant enjoyment (49). Another study found that group MBT-AS had acceptable attendance and drop-out rates (53). Additionally, high levels of attendance, retention, homework compliance and treatment credibility were reported regarding group ACT (56) One study reported a high attendance rate to adapted CBT for anxiety (45). A study of CBT for anxiety (58) and a study of schema therapy (55) reported low drop-out rates. Most participants found the adaptations (i.e., use of visualisation) of CBT for anxiety to be helpful (50). Drop-out rate of CBT for OCD was low and homework compliance was adequate to good, however, attendance rate was low (51).

### Mental health service adaptations

Overall, strategies to improve clinicians’ knowledge of autism and provide environmental adjustments in services were evaluated as acceptable and feasible (46–48). Several service adaptations were reported as frequently implemented in services by staff (39,44). Additionally, self-report tools were found to discriminate autistic and non-autistic people (40,41). Table 5 presents findings of evaluations of strategies at service level intended to improve care.

View this table:
[Table 5.](http://medrxiv.org/content/early/2023/03/10/2023.03.10.23287101/T5)

Table 5. 
Main findings of mental health service adaptations

#### Service evaluations

Three studies examined clinical pathways, models and networks to improve mental health care for autistic people. The Pathway for Eating Disorders and Autism developed from Clinical Experience (PEACE) aimed to introduce autism specific-training, create an autism-friendly ward and support sensory difficulties and communication (48). The pathway resulted in more reductions in the cost and average duration of hospital admissions in autistic individuals with eating disorders than non-autistic individuals with eating disorders. Evaluation of the PEACE pathway suggested that confidence of clinicians in supporting autistic people with co-occurring eating disorder increased following its implementation.

Project Extension for Community Healthcare Outcomes (ECHO) utilised a tele-mentoring platform to connect primary care providers to increase knowledge of autism and co-occurring mental health difficulties and to appropriately adapt treatments (46). Project ECHO was attended by most mental health providers, and increased knowledge, self-efficacy, and awareness in best-practice treatment considerations for autistic individuals was reported post-ECHO sessions. The project was also viewed positively and was rated highly on satisfaction.

Another study reported significant improvements in the proportion of psychiatric disorders from referral to after 12 months, which were sustained from 12 months to 24-27 months post-implementation of the Autism Intellectual disability and psychiatric disorder (AUP) network (47). The AUP network aimed to improve access and quality of tailored services for autistic adults with ID and increase knowledge of clinicians of how mental health difficulties present in autistic people.

#### Perspectives of staff

Two studies identified service adaptations. One survey reported that the most frequent adaptations within inpatient units involved the use of assessments and open access/on request low-stimulus area, and the ability to adapt meal plans (over 50% of units), whilst lighting adaptations, scheduled access low-stimulus area and the use of specific protocols were used less frequently (less than 50% of units) (44). Another qualitative study also reported a range of adaptations identified by staff, including environmental adjustments, communication modifications and consideration of gender, the majority of which were frequently used and perceived as important (39).

#### Detection of autism

Two studies involved application in routine settings of autism screening instrument with the aim of improving detection within mental health services. One survey found that the autism-spectrum quotient (AQ) and the Ritvo autism–Asperger’s diagnostic scale-revised (RAADS-R) can identify fairly accurately autistic individuals from inpatient, outpatient and community mental health services (41). A retrospective study reported that an autism spectrum disorder discriminant function (ASD-DF) derived from the Personality Assessment Inventory (PAI) can discriminate between a sample of autistic participants from a contrasting inpatient sample (40).

### Bespoke strategies to improve mental health care for autistic people

Most bespoke mental health interventions were evaluated as feasible and acceptable, apart from one study of RTSM (52), which demonstrated limited feasibility and acceptability. Evidence on effectiveness was inconclusive. Table 6 presents findings of evaluations of bespoke mental health interventions designed for autistic people.

View this table:
[Table 6.](http://medrxiv.org/content/early/2023/03/10/2023.03.10.23287101/T6)

Table 6. 
Main findings of bespoke strategies to improve mental health care for autistic people

#### Pilot randomised controlled trials (RCTs)

Two pilot RCTs evaluated bespoke mental health interventions. One pilot cross-over trial reported no significant differences between group CBT for anxiety and waiting list, in primary (clinician-assessed anxiety) and secondary mental health and social outcomes (self-report anxiety, depression, social phobia, functioning) (32). Additionally, attendance and drop-out rates in the CBT group were acceptable and reports from participants showed that the intervention was found helpful (32). Specifically, CBT participants felt supported by others, found listening to others’ problems helpful, and experienced less anxiety. Participants also reported enjoying the interaction with others during the sessions. However, they noted the need for longer sessions, and it was suggested that individual rather than group-based delivery might be positive. Another pilot trial, comparing individual AAT with a waiting list, reported no significant differences between the two groups in all mental health outcomes, however AAT had acceptable attendance and drop-out rates (34). Findings on effectiveness in both trials were inconclusive as these were not sufficiently powered to show an effect.

#### Non-randomised controlled trials

Only one non-randomised controlled trial evaluated bespoke mental health interventions. No significant differences between group CBT and waiting list were found, but subsequent analysis showed that participants who scored higher on measures of depression, anxiety and stress benefited the most from the intervention (35). The study also reported a low drop-out rate, but attendance rate could not be determined, as it was unclear how many completed the intervention (35).

#### Before-and-after comparison studies

Three before-and-after comparison studies investigated bespoke mental health interventions. Significant improvements in outcomes over time were reported (Table 6). However, causality cannot be inferred as there were no comparison groups, hence these will not be reported in detail.

A study of individual CBT for anxiety in combination with Virtual Reality reported low drop-out rates (54). Similarly, a study of group CBT for social anxiety reported acceptable attendance and drop-out rates (57). Qualitative reports from participants indicated that the intervention helped them meet others and feel more confident in social situations, while some stated that they would have benefited from additional practical strategies. Another study examining the use of RTSM reported an acceptable drop-out rate, but the engagement rate was low (52). Participants receiving RTSM indicated acceptable use of the intervention, but also reported frustration when it interfered with their daily lives (52).

### Predictors of outcome

Four studies explored relevant predictors of treatment outcome, including demographic variables, autism diagnosis, co-occurring mental health difficulties and verbal Intelligence Quotient (IQ), but all were shown to have no effect on change in outcomes (Table S12).

## Discussion

The current systematic review aimed to identify strategies used to improve mental health care for autistic adults and examine their feasibility, acceptability and effectiveness. A total of 29 studies were included. A variety of approaches to adapted and bespoke mental health interventions and service improvements were identified.

Most studies reported on strategies that were adapted mental health interventions. These were largely CBT-based, targeting anxiety or a combination of mental health difficulties, with a few targeting depression and OCD. Adaptations to these interventions included mainly communication accommodations, modifications to their structure and content and tailoring treatment to individual differences. We also identified service adaptations aimed to improve mental health care for autistic people and the identification of autism. Adaptations to services included communication accommodations, increasing knowledge of clinicians and detection of autism, environmental adjustments and accommodating individual differences. Bespoke mental health interventions of CBT for social anxiety, CBT for anxiety in combination with VR, AAT and RTSM were also identified.

Evidence on effectiveness of the strategies was generally of low quality and inconclusive, as most included studies lacked a comparison group and RCTs were not sufficiently powered to detect significant differences between groups. Moreover, there were no trials comparing adapted and non-adapted mental health interventions; consequently, the extent to which adaptations were an improvement on standard mental health interventions could not be determined.

Overall, most bespoke and adapted mental health interventions appeared to be acceptable and feasible. Furthermore, qualitative evidence from participants showed that adaptations such as visualisation (50) in CBT for anxiety and the use of simple language and a concrete and structured approach in guided self-help CBT for depression (38) were perceived as helpful. However, the pacing of sessions of guided self-help CBT for depression and the use of pre-defined visual tools received differing views (38). Therapists reported frequently using adaptations related to communication, content of the intervention and adjustment of treatment to individual needs when delivering CBT and EMDR to autistic people (42,43). However, one study with service users reported limited feasibility of adapted CBT for OCD, which could be attributed to difficulties attending sessions regularly (51). Another study demonstrated limited feasibility and acceptability of bespoke RTSM (52), as the unpredictability of the intervention led to frustration and interference with life.

Autism-tailored service pathways and models were found to be acceptable and feasible, suggesting that the introduction of autism-specific training could develop clinician’s knowledge and skills and subsequently improve care. Initiatives to improve the identification of autism also indicated that the use of AQ, RAADS-R and ASD-DF to identify potentially autistic people could be helpful for screening for autism in mental health settings, and subsequent referral to specialist autism assessment (40,41). However, only two studies investigated the detection of autism, despite the perceived misdiagnosis of autism and the impact this may have on treatment (16).

A variety of adaptations to services and interventions that are acceptable and feasible to implement in mental health care were identified. Many of these adaptations have been prioritised by autistic adults (59), including improving communication, providing environmental adjustments and developing knowledge of autism in clinicians. This is a promising finding, as it demonstrates that autistic people’s priorities are being taken into consideration. However, some adaptations (e.g., communication) were more frequently used than others (e.g., environmental adjustments, clinician knowledge, detection of autism), indicating that there may be scope for further improvement in service provision.

Notably, we identified a lack of comprehensive descriptions of how interventions were adapted and why. Furthermore, no tailored pharmacological interventions or prescription initiatives were found, regardless of the common use of psychotropic medication (60), which is perceived as inappropriate by some autistic people (11), highlighting a potential gap. Other notable gaps include evidence on what works for autistic people with ID, suggesting a selection bias against participants with ID (61), and evidence on supporting autistic people with severe or long-term mental health difficulties including high levels of suicidality and self-harm. These are important areas in the context of the disproportionate detention of autistic people to psychiatric wards (62).

The current review also piloted a novel and lived experience researcher-led approach to identifying neurotypical biases in studies. Only 24% of studies involved autistic individuals, hence co-produced research is lacking. Additionally, selection of outcomes measures and data collection methods in many of the papers demonstrated a lack of adjustments to facilitate wider participation, some interventions appeared to focus on masking autistic traits and language used showed a deficit approach to autism (63,64).

### Strengths and limitations

The current review identified a list of adaptations that have been implemented across the service pathway, which may be helpful for tailoring treatments and services to the needs of autistic people. Another key strength is that the review was co-produced with lived experience researchers, who were involved in all aspects of the review, including protocol development, article screening, data extraction and synthesis, neurotypical bias assessment, interpretation of findings, write-up and dissemination. We used the GRADE framework to assess quality of evidence for effectiveness and integrated it within our narrative synthesis.

A limitation is that most studies included in the review had a small sample and lacked a comparison group preventing us from attributing any improvements in outcomes to the intervention alone, and where there were comparisons, they were not with a non-adapted intervention hindering any conclusions on effects of adaptations. A further limitation is that a high proportion of participants were white and male, neglecting under-represented groups such as black and ethnic minorities and other gender identities. Differences associated with sex/gender, ethnicities and cultures may be implicated in the presentation of autistic traits and may impact how adaptations are received by these groups, thus should be taken into consideration (65–68). Additionally, research on different types of strategies (e.g., adaptations to pharmacological interventions) and research including autistic people with ID and severe or long-term mental health difficulties was notably missing.

### Clinical implications and future directions

The current review highlighted a list of strategies evaluated as acceptable and simple to implement, such as improving communication and providing environmental adjustments, that do not necessarily require a further RCT evaluation. An individually tailored approach to treatment may be particularly helpful and facilitate appropriate mental health care, as autistic people differ in their support needs and the presentation of autistic traits (69,70). Nevertheless, a balance should be struck between tailoring treatment to individual differences and adhering to evidence-based practice, which could possibly be addressed through a neurodivergence-informed approach to therapy and primary research (25).

Future research should investigate a co-produced package of mental health service improvement measures. There is also a need for recruitment strategies that increase participation from under-represented groups and reduce biases (e.g., male bias); and for an increased focus on those with ID and/or severe or long-term mental health difficulties.

## Declaration of Interest

None.

## Funding

This paper presents independent research commissioned and funded by the National Institute for Health Research (NIHR) Policy Research Programme and conducted by the NIHR Mental Health Policy Research Unit (MHPRU). The funder has no role in the study design, data analysis, write-up of the manuscript or the decision to submit for publication.

## Author Contribution

The working group collaboratively conceived and formulated the review questions. TS conducted the searches. TP, AG, AK, TS, DS, SL, RC, JG, HB, UF, KS contributed to the screening and TP, AG, AK, TS, DS, UF, SL, JG, HB, AT, MM, GB, RC extracted data. SL, TP and TS collaboratively drafted the manuscript. TS, TP, SL, PB, RC, KS, VT, SJ, NA, RJ, JP, AT, RP, BC, WM, AS, PC, RRO, SZ contributed to the editing of the manuscript. All authors have approved the final manuscript.

## Data Availability

Data were collected from publicly available research papers which are referenced.

## Supporting information

Supplementary material [[supplements/287101_file03.docx]](pending:yes)

## Data Availability

Data were collected from publicly available research papers which are referenced.

## Footnotes

*   1 Whilst there are different terms used to refer to people on the autism spectrum, in this review we are using identity-first language (e.g., “autistic person”)

*   Received March 10, 2023.
*   Revision received March 10, 2023.
*   Accepted March 10, 2023.


*   © 2023, Posted by Cold Spring Harbor Laboratory

This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at [http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/)

## References

1.  1.Kenny L, Hattersley C, Molins B, Buckley C, Povey C, Pellicano E. Which terms should be used to describe autism? Perspectives from the UK autism community. Autism. 2016 May 1;20(4):442–62. doi: 10.1177/1362361315588200
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1177/1362361315588200&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=26134030&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F03%2F10%2F2023.03.10.23287101.atom) 

2.  2.Mandy W. Six ideas about how to address the autism mental health crisis. Autism. 2022. Feb;26(2):289–92. doi: 10.1177/13623613211067928
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1177/13623613211067928&link_type=DOI) 

3.  3.Knüppel A, Telléus GK, Jakobsen H, Lauritsen MB. Quality of life in adolescents and adults with autism spectrum disorder: Results from a nationwide Danish survey using self-reports and parental proxy-reports. Research in Developmental Disabilities. 2018 Dec 1;83:247–59. doi: 10.1016/j.ridd.2018.09.004
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.ridd.2018.09.004&link_type=DOI) 

4.  4.Lawson LP, Richdale AL, Haschek A, Flower RL, Vartuli J, Arnold SRC, et al. Cross-sectional and longitudinal predictors of quality of life in autistic individuals from adolescence to adulthood: The role of mental health and sleep quality. Autism. 2020 May 1;24(4):954–67. doi: 10.1177/1362361320908107
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1177/1362361320908107&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F03%2F10%2F2023.03.10.23287101.atom) 

5.  5.Mason D, Mackintosh J, McConachie H, Rodgers J, Finch T, Parr JR. Quality of life for older autistic people: The impact of mental health difficulties. Research in Autism Spectrum Disorders. 2019 Jul 1;63:13–22. doi: 10.1016/j.rasd.2019.02.007
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.rasd.2019.02.007&link_type=DOI) 

6.  6.Cassidy S, Bradley L, Shaw R, Baron-Cohen S. Risk markers for suicidality in autistic adults. Molecular Autism. 2018 Dec;9:1–4. doi: 10.1186/s13229-018-0226-4
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1186/s13229-018-0226-4&link_type=DOI) 

7.  7.Hedley D, Uljarević M, Wilmot M, Richdale A, Dissanayake C. Brief Report: Social Support, Depression and Suicidal Ideation in Adults with Autism Spectrum Disorder. Journal of Autism Developmental Disorders. 2017 Nov;47:3669–77. doi: 10.1007/s10803-017-3274-2
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1007/s10803-017-3274-2&link_type=DOI) 

8.  8.Rydén E, Hetta J. Borderline personality disorder and autism spectrum disorder in females: A cross-sectional study. Clinical Neuropsychiatry. 2008 Feb;5(1):22–30.
    
    

9.  9.Vogan V, Lake JK, Tint A, Weiss JA, Lunsky Y. Tracking health care service use and the experiences of adults with autism spectrum disorder without intellectual disability: A longitudinal study of service rates, barriers and satisfaction. Disability and Health Journal. 2017 Apr 1;10(2):264–70. doi: 10.1016/j.dhjo.2016.11.002
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.dhjo.2016.11.002&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F03%2F10%2F2023.03.10.23287101.atom) 

10. 10.Nicolaidis C, Raymaker D, McDonald K, Dern S, Boisclair WC, Ashkenazy E, et al. Comparison of healthcare experiences in autistic and non-autistic adults: a cross-sectional online survey facilitated by an academic-community partnership. Journal of General Internal Medicine. 2013 Jun;28:761–9. doi: 10.1007/s11606-012-2262-7
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1007/s11606-012-2262-7&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=23179969&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F03%2F10%2F2023.03.10.23287101.atom) 

11. 11.Brede J, Cage E, Trott J, Palmer L, Smith A, Serpell L, et al. “We Have to Try to Find a Way, a Clinical Bridge” - autistic adults’ experience of accessing and receiving support for mental health difficulties: A systematic review and thematic meta-synthesis. Clinical Psychology Review. 2022 April 1;93:102131. doi: 10.1016/j.cpr.2022.102131
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.cpr.2022.102131&link_type=DOI) 

12. 12.Lai MC, Baron-Cohen S. Identifying the lost generation of adults with autism spectrum conditions. Lancet Psychiatry. 2015 Nov 1;2(11):1013–27.doi: 10.1016/S2215-0366(15)00277-1
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/S2215-0366(15)00277-1&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=26544750&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F03%2F10%2F2023.03.10.23287101.atom) 

13. 13.Råstam M. Eating disturbances in autism spectrum disorders with focus on adolescent and adult years. Clinical Neuropsychiatry: Journal of Treatment Evaluation. 2008 Feb.
    
    

14. 14.Stewart ME, Barnard L, Pearson J, Hasan R, O’Brien G. Presentation of depression in autism and Asperger syndrome: A review. Autism. 2006 Jan;10(1):103–16. doi: 10.1177/1362361306062013
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1177/1362361306062013&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=16522713&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F03%2F10%2F2023.03.10.23287101.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000236703500008&link_type=ISI) 

15. 15.Adams D, Young K. A Systematic review of the perceived barriers and facilitators to accessing psychological treatment for mental health problems in individuals on the autism spectrum. Review Journal of Autism and Developmental Disorders. 2020:1–8. doi: 10.1007/s40489-020-00226-7
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1007/s40489-020-00226-7&link_type=DOI) 

16. 16.Au-Yeung SK, Bradley L, Robertson AE, Shaw R, Baron-Cohen S, Cassidy S. Experience of mental health diagnosis and perceived misdiagnosis in autistic, possibly autistic and non-autistic adults. Autism. 2019 Aug;23(6):1508–18. doi: 10.1177/1362361318818167
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1177/1362361318818167&link_type=DOI) 

17. 17.Ainsworth K, Robertson AE, Welsh H, Day M, Watt J, Barry F, Stanfield A, Melville C. Anxiety in adults with autism: Perspectives from practitioners. Research in Autism Spectrum Disorders. 2020 Jan 2;69:101457. doi: 10.1016/j.rasd.2019.101457
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.rasd.2019.101457&link_type=DOI) 

18. 18.Spain D, Rumball F, O’Neill L, Sin J, Prunty J, Happé F. Conceptualizing and treating social anxiety in autism spectrum disorder: A focus group study with multidisciplinary professionals. Journal of Applied Research in Intellectual Disabilities. 2017 Dec;30:10– 21. doi: 10.1111/jar.12320
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1111/jar.12320&link_type=DOI) 

19. 19.Babb C, Brede J, Jones CRG, Elliott M, Zanker C, Tchanturia K, Serpell L, Mandy W, Fox JR. ‘It’s not that they don’t want to access the support… it’s the impact of the autism’: The experience of eating disorder services from the perspective of autistic women, parents and healthcare professionals. Autism. 2021 Jul 1;25(5):1409–21. doi: 10.1177/1362361321991257
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1177/1362361321991257&link_type=DOI) 

20. 20.Babb C, Brede J, Jones CRG, Serpell L, Mandy W, Fox J. A comparison of the eating disorder service experiences of autistic and non-autistic women in the UK. European Eating Disorders Review. 2022 Sep;30(5):616–27. doi: 10.1002/erv.2930
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1002/erv.2930&link_type=DOI) 

21. 21.Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. International Journal of Surgery. 2021 Apr 1;88:105906. doi: 10.1016/j.ijsu.2021.105906
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.ijsu.2021.105906&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=33789826&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F03%2F10%2F2023.03.10.23287101.atom) 

22. 22.Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Systematic Reviews. 2016 Dec;5:1–. doi: 10.1186/s13643-016-0384-4
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1186/s13643-016-0384-4&link_type=DOI) 

23. 23.Benford P, Standen PJ. The use of email-facilitated interviewing with higher functioning autistic people participating in a grounded theory study. International Journal of Social Research Methodology. 2011 Sep 1;14(5):353–68. doi: 10.1080/13645579.2010.534654
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1080/13645579.2010.534654&link_type=DOI) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000299901900002&link_type=ISI) 

24. 24.Nicolaidis C, Raymaker DM, McDonald KE, Lund EM, Leotti S, Kapp SK, Katz M, Beers LM, Kripke C, Maslak J, Hunter M. Creating accessible survey instruments for use with autistic adults and people with intellectual disability: Lessons learned and recommendations. Autism in Adulthood. 2020 Mar 1;2(1):61–76. doi: 10.1089/aut.2019.0074
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1089/aut.2019.0074&link_type=DOI) 

25. 25.Chapman R, Botha M. Neurodivergence-informed therapy. Developmental Medicine and Child Neurology. 2023 Mar;65(3):310–7. doi: 10.1111/dmcn.15384
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1111/dmcn.15384&link_type=DOI) 

26. 26.Hong QN, Fàbregues S, Bartlett G, Boardman F, Cargo M, Dagenais P, Gagnon MP, Griffiths F, Nicolau B, O’Cathain A, Rousseau MC. The Mixed Methods Appraisal Tool (MMAT) version 2018 for information professionals and researchers. Education for Information. 2018 Jan 1;34(4):285–91. doi: 10.3233/EFI-180221
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.3233/EFI-180221&link_type=DOI) 

27. 27.Guyatt G, Oxman AD, Vist G, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008 April 24;336(7650):924–6. doi: 10.1136/bmj.39489.470347.AD
    
    [FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiRlVMTCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiYm1qIjtzOjU6InJlc2lkIjtzOjEyOiIzMzYvNzY1MC85MjQiO3M6NDoiYXRvbSI7czo1MDoiL21lZHJ4aXYvZWFybHkvMjAyMy8wMy8xMC8yMDIzLjAzLjEwLjIzMjg3MTAxLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==) 

28. 28.Murad MH, Mustafa RA, Schünemann HJ, Sultan S, Santesso N. Rating the certainty in evidence in the absence of a single estimate of effect. Evidence-Based Medicine. 2017 Mar 20. doi: 10.1136/ebmed-2017-110668
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NToiZWJtZWQiO3M6NToicmVzaWQiO3M6NzoiMjIvMy84NSI7czo0OiJhdG9tIjtzOjUwOiIvbWVkcnhpdi9lYXJseS8yMDIzLzAzLzEwLzIwMjMuMDMuMTAuMjMyODcxMDEuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9) 

29. 29.Popay J, Roberts H, Sowden A, Petticrew M, Arai L, Rodgers M, Britten N, Roen K, Duffy S. Guidance on the Conduct of Narrative Synthesis in Systematic Reviews. A product from the ESRC methods programme Version. 2006 April 1;1(1):b92.
    
    

30. 30.Russell AJ, Jassi A, Fullana MA, Mack H, Johnston K, Heyman I, Murphy DG, Mataix-Cols D. Cognitive behavior therapy for comorbid obsessive-compulsive disorder in high-functioning autism spectrum disorders: A randomized controlled trial. Depression and Anxiety. 2013 Aug;30(8):697–708. doi: 10.1002/da.22053
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1002/da.22053&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=23389964&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F03%2F10%2F2023.03.10.23287101.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000322583800001&link_type=ISI) 

31. 31.Spek AA, van Ham NC, Nyklíček I. Mindfulness-based therapy in adults with an autism spectrum disorder: a randomized controlled trial. Research in Developmental Disabilities. 2013 Jan 1;34(1):246–53. doi: 10.1016/j.ridd.2012.08.009
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.ridd.2012.08.009&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=22964266&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F03%2F10%2F2023.03.10.23287101.atom) 

32. 32.Langdon PE, Murphy GH, Shepstone L, Wilson ECF, Fowler D, Heavens D, et al. The People with Asperger syndrome and anxiety disorders (PAsSA) trial: a pilot multicentre, single-blind randomised trial of group cognitive–behavioural therapy. BJPsych Open. 2016 Mar;2(2):179–86. doi: 10.1192/bjpo.bp.115.002527
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MTE6ImJqcG9yY3BzeWNoIjtzOjU6InJlc2lkIjtzOjc6IjIvMi8xNzkiO3M6NDoiYXRvbSI7czo1MDoiL21lZHJ4aXYvZWFybHkvMjAyMy8wMy8xMC8yMDIzLjAzLjEwLjIzMjg3MTAxLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==) 

33. 33.Russell A, Gaunt DM, Cooper K, Barton S, Horwood J, Kessler D, Metcalfe C, Ensum I, Ingham B, Parr JR, Rai D. The feasibility of low-intensity psychological therapy for depression co-occurring with autism in adults: The Autism Depression Trial (ADEPT) – a pilot randomised controlled trial. Autism. 2020 Aug 1;24(6):1360–72. doi: 10.1177/1362361319889272
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1177/1362361319889272&link_type=DOI) 

34. 34.Wijker C, Leontjevas R, Spek A, Enders-Slegers MJ. Effects of Dog Assisted Therapy for Adults with Autism Spectrum Disorder: An Exploratory Randomized Controlled Trial. Journal of Autism and Developmental Disorders. 2020 Jun;50(6):2153–63. doi: 10.1007/s10803-019-03971-9
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1007/s10803-019-03971-9&link_type=DOI) 

35. 35.McGillivray JA, Evert HT. Group cognitive behavioural therapy program shows potential in reducing symptoms of depression and stress among young people with ASD. Journal of Autism and Developmental Disorders. 2014 Aug;44(8):2041–51. doi: 10.1007/s10803-014-2087-9
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1007/s10803-014-2087-9&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=24634065&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F03%2F10%2F2023.03.10.23287101.atom) 

36. 36. Lobregt-van Buuren E, Sizoo B, Mevissen L, de Jongh A. Eye movement desensitization and reprocessing (EMDR) therapy as a feasible and potential effective treatment for adults with autism spectrum disorder (ASD) and a history of adverse events. Journal of Autism and Developmental Disorders. 2019 Jan 15;49(1):151–64. doi: 10.1007/s10803-018-3687-6
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1007/s10803-018-3687-6&link_type=DOI) 

37. 37.Sizoo BB, Kuiper E. Cognitive behavioural therapy and mindfulness based stress reduction may be equally effective in reducing anxiety and depression in adults with autism spectrum disorders. Research in Developmental Disabilities. 2017 May 1;64:47–55. doi: 10.1016/j.ridd.2017.03.004
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.ridd.2017.03.004&link_type=DOI) 

38. 38.Horwood J, Cooper K, Harvey H, Davies L, Russell A. The experience of autistic adults accessing adapted cognitive behaviour therapy: ADEPT (Autism Depression Trial) qualitative evaluation. Research in Autism Spectrum Disorders. 2021 Aug 1;86:101802. doi: 10.1016/j.rasd.2021.101802
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.rasd.2021.101802&link_type=DOI) 

39. 39.Petty S, Bergenheim ML, Mahoney G, Chamberlain L. Adapting services for autism: Recommendations from a specialist multidisciplinary perspective using freelisting. Current Psychology. 2021 Jul 16:1–2. doi: 10.1007/s12144-021-02061-3
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1007/s12144-021-02061-3&link_type=DOI) 

40. 40.Harrison KB, McCredie MN, Reddy MK, Krishnan A, Engstrom A, Posey YS, Morey LC, Loveland KA. Assessing autism spectrum disorder in intellectually able adults with the personality assessment Inventory: Normative Data and a Novel Supplemental Indicator. Journal of Autism and Developmental Disorders. 2020 Nov;50:3935–43. doi: 10.1007/s10803-020-04450-2
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1007/s10803-020-04450-2&link_type=DOI) 

41. 41.Brugha T, Tyrer F, Leaver A, Lewis S, Seaton S, Morgan Z, Tromans S, van Rensburg K. Testing adults by questionnaire for social and communication disorders, including autism spectrum disorders, in an adult mental health service population. International Journal of Methods in Psychiatric Research. 2020 Mar;29(1):e1814. doi: 10.1002/mpr.1814
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1002/mpr.1814&link_type=DOI) 

42. 42.Cooper K, Loades ME, Russell A. Adapting psychological therapies for autism. Research in Autism Spectrum Disorders. 2018 Jan;45:43–50. doi: 10.1016/j.rasd.2017.11.002
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.rasd.2017.11.002&link_type=DOI) 

43. 43.Fisher N, van Diest C, Leoni M, Spain D. Using EMDR with autistic individuals: A Delphi survey with EMDR therapists. Autism. 2023 Jan;27(1):43–53. doi: 10.1177/13623613221080254
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1177/13623613221080254&link_type=DOI) 

44. 44.Jones K, Gangadharan S, Brigham P, Smith E, Shankar R. Current practice and adaptations being made for people with autism admitted to in-patient psychiatric services across the UK. BJPsych Open. 2021 May;7(3):e102. doi: 10.1192/bjo.2021.58
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1192/bjo.2021.58&link_type=DOI) 

45. 45.Blainey SH, Rumball F, Mercer L, Evans LJ, Beck A. An evaluation of the effectiveness of psychological therapy in reducing general psychological distress for adults with autism spectrum conditions and comorbid mental health problems. Clinical Psychology & Psychotherapy. 2017 Nov;24(6):O1474–84. doi: 10.1002/cpp.2108
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1002/cpp.2108&link_type=DOI) 

46. 46.Dreiling NG, Cook ML, Lamarche E, Klinger LG. Mental health Project ECHO Autism: Increasing access to community mental health services for autistic individuals. Autism. 2022 Feb;26(2):434–45. doi: 10.1177/13623613211028000
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1177/13623613211028000&link_type=DOI) 

47. 47.Helverschou SB, Bakken TL, Berge H, Bjørgen TG, Botheim H, Hellerud JA, Helseth I, Hove O, Johansen PA, Kildahl AN, Ludvigsen LB. Preliminary findings from a nationwide, multicenter mental health service for adults and older adolescents with autism spectrum disorder and ID. Journal of Policy and Practice in Intellectual Disabilities. 2021 Jun;18(2):162–73. doi: 10.1111/jppi.12366
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1111/jppi.12366&link_type=DOI) 

48. 48.Tchanturia K, Dandil Y, Li Z, Smith K, Leslie M, Byford S. A novel approach for autism spectrum condition patients with eating disorders: Analysis of treatment cost-savings. European Eating Disorders Review. 2021 May;29(3):514–8. doi: 10.1002/erv.2760
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1002/erv.2760&link_type=DOI) 

49. 49.Bemmer ER, Boulton KA, Thomas EE, Larke B, Lah S, Hickie IB, Guastella AJ. Modified CBT for social anxiety and social functioning in young adults with autism spectrum disorder. Molecular Autism. 2021 Dec;12(1):1–5. doi: 10.1186/s13229-021-00418-w
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1186/s13229-021-00418-w&link_type=DOI) 

50. 50.Ekman E, Hiltunen AJ. Modified CBT using visualization for autism spectrum disorder (ASD), anxiety and avoidance behavior - a quasi-experimental open pilot study.
    
    

51. 51.Flygare O, Andersson E, Ringberg H, Hellstadius AC, Edbacken J, Enander J, Dahl M, Aspvall K, Windh I, Russell A, Mataix-Cols D. Adapted cognitive behavior therapy for obsessive–compulsive disorder with co-occurring autism spectrum disorder: A clinical effectiveness study. Autism. 2020 Jan;24(1):190–9. doi: 10.1177/1362361319856974
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1177/1362361319856974&link_type=DOI) 

52. 52.Hare DJ, Gracey C, Wood C. Anxiety in high-functioning autism: A pilot study of experience sampling using a mobile platform. Autism. 2016 Aug;20(6):730–43. doi: 10.1177/1362361315604817
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1177/1362361315604817&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=26514793&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F03%2F10%2F2023.03.10.23287101.atom) 

53. 53.Kiep M, Spek AA, Hoeben L. Mindfulness-based therapy in adults with an autism spectrum disorder: Do treatment effects last? Mindfulness. 2015 Jun;6(3):637–44. doi: 10.1007/s12671-014-0299-x
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1007/s12671-014-0299-x&link_type=DOI) 

54. 54.Maskey M, Rodgers J, Ingham B, Freeston M, Evans G, Labus M, Parr JR. Using virtual reality environments to augment cognitive behavioral therapy for fears and phobias in autistic adults. Autism in Adulthood. 2019 Jun 1;1(2):134–45. doi: 10.1089/aut.2018.0019
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1089/aut.2018.0019&link_type=DOI) 

55. 55.Oshima F, Murata T, Ohtani T, Seto M, Shimizu E. A preliminary study of schema therapy for young adults with high-functioning autism spectrum disorder: a single-arm, uncontrolled trial. BMC Research Notes. 2021 Dec;14(1):1–8. doi: 10.1186/s13104-021-05556-1
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1186/s13104-021-05556-1&link_type=DOI) 

56. 56.Pahnke J, Hirvikoski T, Bjureberg J, Bölte S, Jokinen J, Bohman B, et al. Acceptance and commitment therapy for autistic adults: An open pilot study in a psychiatric outpatient context. Journal of Contextual Behavioral Science. 2019 Jul 1;13:34–41. doi: 10.1016/j.jcbs.2019.04.002
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.jcbs.2019.04.002&link_type=DOI) 

57. 57.Spain D, Blainey SH, Vaillancourt K. Group cognitive behaviour therapy (CBT) for social interaction anxiety in adults with autism spectrum disorders (ASD). Research in Autism Spectrum Disorders. 2017 Sep 1;41–42:20–30. Doi: 10.1016/j.rasd.2017.07.005
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.rasd.2017.07.005&link_type=DOI) 

58. 58.Wise JM, Cepeda SL, Ordaz DL, McBride NM, Cavitt MA, Howie FR, Scalli L, Ehrenreich-May J, Wood JJ, Lewin AB, Storch EA. Open Trial of Modular Cognitive-Behavioral Therapy in the Treatment of Anxiety Among Late Adolescents with Autism Spectrum Disorder. Child Psychiatry & Human Development. 2019 Feb 15;50:27–34. doi: 10.1007/s10578-018-0817-5
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1007/s10578-018-0817-5&link_type=DOI) 

59. 59.Brice S, Rodgers J, Ingham B, Mason D, Wilson C, Freeston M, Le Couteur A, Parr JR. The importance and availability of adjustments to improve access for autistic adults who need mental and physical healthcare: Findings from UK surveys. BMJ Open. 2021 Mar 1;11(3):e043336. doi: 10.1136/bmjopen-2020-043336
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NzoiYm1qb3BlbiI7czo1OiJyZXNpZCI7czoxMjoiMTEvMy9lMDQzMzM2IjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjMvMDMvMTAvMjAyMy4wMy4xMC4yMzI4NzEwMS5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 

60. 60.Nylander L, Axmon A, Björne P, Ahlström G, Gillberg C. Older adults with autism spectrum disorders in Sweden: A register study of diagnoses, psychiatric care utilization and psychotropic medication of 601 individuals. Journal of Autism and Developmental Disorders. 2018 Sep;48:3076–85. doi: 10.1007/s10803-018-3567-0
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1007/s10803-018-3567-0&link_type=DOI) 

61. 61.Russell G, Mandy W, Elliott D, White R, Pittwood T, Ford T. Selection bias on intellectual ability in autism research: A cross-sectional review and meta-analysis. Molecular Autism. 2019 Dec;10(1):1–. doi: 10.1186/s13229-019-0260-x
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1186/s13229-019-0260-x&link_type=DOI) 

62. 62.National Autistic Society. Number of autistic people in mental health hospitals: latest data [internet]. 2022 [cited 2023 Mar 7]. Available from: [https://www.autism.org.uk/what-we-do/news/autistic-people-in-mental-health-hospitals](https://www.autism.org.uk/what-we-do/news/autistic-people-in-mental-health-hospitals)
    
    

63. 63.Dinishak J. The Deficit View and Its Critics. Disability Studies Quarterly. 2016 Dec 2;36(4). doi: 10.18061/dsq.v36i4.5236
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.18061/dsq.v36i4.5236&link_type=DOI) 

64. 64.Milton DEM. On the ontological status of autism: The ‘double empathy problem’. Disability & Society. 2012 Oct 1;27(6):883–7. doi: 10.1080/09687599.2012.710008
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1080/09687599.2012.710008&link_type=DOI) 

65. 65.Carruthers S, Kinnaird E, Rudra A, Smith P, Allison C, Auyeung B, Chakrabarti B, Wakabayashi A, Baron-Cohen S, Bakolis I, Hoekstra RA. A cross-cultural study of autistic traits across India, Japan and the UK. Molecular Autism. 2018 Dec;9:1–4. doi: 10.1186/s13229-018-0235-3
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1186/s13229-018-0226-4&link_type=DOI) 

66. 66.Hull L, Lai MC, Baron-Cohen S, Allison C, Smith P, Petrides K V., Mandy W. Gender differences in self-reported camouflaging in autistic and non-autistic adults. Autism. 2020 Feb;24(2):352–63. doi: 10.1177/1362361319864804
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1177/1362361319864804&link_type=DOI) 

67. 67.Hull L, Petrides K V, Mandy W. The female autism phenotype and camouflaging: a narrative review. Review Journal of Autism and Developmental Disorders. 2020 Dec;7:306–17. doi: 10.1007/s40489-020-00197-9
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1007/s40489-020-00197-9&link_type=DOI) 

68. 68.Pender R, Fearon P, Heron J, Mandy W. The longitudinal heterogeneity of autistic traits: A systematic review. Research in Autism Spectrum Disorders. 2020 Nov 1;79:101671. doi: 10.1016/j.rasd.2020.101671
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.rasd.2020.101671&link_type=DOI) 

69. 69.Uljarević M, Baranek G, Vivanti G, Hedley D, Hudry K, Lane A. Heterogeneity of sensory features in autism spectrum disorder: Challenges and perspectives for future research. Autism Research. 2017 May;10(5):703–10. doi: 10.1002/aur.1747
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1002/aur.1747&link_type=DOI) 

70. 70.Robledo J, Donnellan AM, Strandt-Conroy K. An exploration of sensory and movement differences from the perspective of individuals with autism. Frontiers in Integrative Neuroscience. 2012 Nov;16;6:107. doi: 10.3389/fnint.2012.00107
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.3389/fnint.2012.00107&link_type=DOI)